BioCurate was jointly formed by the University of Melbourne and Monash University, with support from the Victorian State Government, and launched in June 2016. Our mission is to grow the Victorian and Australian biotech sector by translating medical research outputs into high quality preclinical therapeutic candidates for the bio-pharmaceutical industry.

BioCurate’s team of experts bring hands-on industry experience and a global track-record, providing a robust bridge between academia and industry within the biotechnology sector to accelerate the development of new therapies.

The company is currently developing and investing in a total of 11 programs in oncology, neurology, immunology and other therapeutic areas.

We aim to build and continue conversations with companies that are seeking novel preclinical therapeutic programs and technologies, and direct investment opportunities.